mifepristone has been researched along with Postpartum Amenorrhea in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, A; Frantz, S; Herman-Demars, H; Quaranta, LM; Sicot, M; Zinovieva, E | 1 |
| Chow, TL; Murji, A; Sobel, ML; Whitaker, L | 1 |
| Bian, M; Geng, L; Huang, M; Liu, C; Lu, Q; Qu, H; Wang, H; Wen, Z; Zhang, Y; Zhang, Z; Zheng, S | 1 |
| Cotte, M; Lefebvre, P; Monniez, N; Norel, G | 1 |
| Boersma, AA; Kleiverda, G; Meyboom-de Jong, B | 1 |
| Bartfai, G; Erdenetungalag, R; Gemzell-Danielsson, K; Gopalan, S; Honkanen, H; Horga, M; Jerve, F; Mittal, S; Ngoc, NT; Peregoudov, A; Piaggio, G; Prasad, RN; Pretnar-Darovec, A; Shah, RS; Song, S; Tang, OS; von Hertzen, H; Wu, SC | 1 |
| Bártfai, G; Erdenetungalag, R; Gemzell-Danielsson, K; Gopalan, S; Hertzen, H; Honkanen, H; Horga, M; Jerve, F; Mittal, S; Peregoudov, A; Piaggio, G; Prasad, RN; Pretnar-Darovec, A; Shah, RS; Song, S; Tang, OS; Thi Nhu Ngoc, N; Wu, SC | 1 |
| Chabbert-Buffet, N; Gelber, H; Grunberg, SM; Lindenberg, T; Sitruk-Ware, R; Spitz, IM | 1 |
| Baird, DT; Cheng, L; Critchley, HO; Narvekar, N | 1 |
| Ambardekar, S; Bracken, H; Coyaji, K; Krishna, U; Mandlekar, A; Raote, V; Winikoff, B | 1 |
| Batista, MC; Cartledge, TP; Loriaux, DL; Merriam, GR; Nieman, LK; Zellmer, AW | 1 |
| Aubény, E; Baulieu, EE; Peyron, R; Renault, M; Silvestre, L; Targosz, V; Turpin, CL; Ulmann, A | 1 |
| Adams, L; Grow, DR; Hodgen, GD; Hsiu, JG; Newcomb, PM; Reece, MT; Williams, RF | 1 |
| Baird, DT; Brown, A; Cheng, L; Lin, S | 1 |
| Baird, DT; Norman, JE; Rodger, MW; Thong, KJ | 1 |
| Kettel, LM; Liu, JH; Mortola, JF; Murphy, AA; Ulmann, A; Yen, SS | 1 |
| Dubois, C; Silvestre, L; Ulmann, A | 1 |
| Dubois, C; Fan, HM; Gao, J; Han, ZB; Meng, U; Qiao, GM; Wu, ME; Wu, YM; Yao, GZ; Zheng, SR | 1 |
| Baulieu, E | 1 |
1 review(s) available for mifepristone and Postpartum Amenorrhea
| Article | Year |
|---|---|
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Topics: Amenorrhea; Antineoplastic Agents, Hormonal; Estrenes; Female; Humans; Leiomyoma; Leuprolide; Menstruation; Mifepristone; Norpregnadienes; Oximes; Pelvic Pain; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2017 |
9 trial(s) available for mifepristone and Postpartum Amenorrhea
| Article | Year |
|---|---|
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial.
Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Dose-Response Relationship, Drug; Dysmenorrhea; Female; Hematologic Tests; Hormone Antagonists; Humans; Leiomyoma; Leuprolide; Middle Aged; Mifepristone | 2017 |
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; Amenorrhea; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Risk Factors; Treatment Outcome | 2003 |
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
Topics: Abdominal Pain; Abortifacient Agents, Steroidal; Abortion, Induced; Amenorrhea; Analgesics; Dizziness; Double-Blind Method; Fatigue; Female; Headache; Humans; Mifepristone; Misoprostol; Nausea; Parity; Patient Satisfaction; Perception; Treatment Outcome; Vomiting | 2004 |
Management of patients receiving long-term treatment with mifepristone.
Topics: Adrenal Insufficiency; Adult; Aged; Aged, 80 and over; Amenorrhea; Drug Monitoring; Endometrial Hyperplasia; Female; Hormone Antagonists; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Mifepristone; Time Factors | 2005 |
Are two doses of misoprostol after mifepristone for early abortion better than one?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Amenorrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Treatment Outcome | 2007 |
The antiprogestin RU486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles.
Topics: Adult; Amenorrhea; Animals; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Menstrual Cycle; Mifepristone; Ovarian Follicle; Ovulation; Placebos; Progestins; Time Factors | 1994 |
Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected].
Topics: Abortifacient Agents; Adolescent; Adult; Amenorrhea; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hemostatic Techniques; Humans; Incidence; Menstruation-Inducing Agents; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic; Time Factors; Ultrasonography; Uterine Hemorrhage; Uterus | 1995 |
Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Menstruation; Mifepristone; Ovulation | 2002 |
Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Amenorrhea; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 1992 |
9 other study(ies) available for mifepristone and Postpartum Amenorrhea
| Article | Year |
|---|---|
Efficacy of mifepristone - Prostaglandin analogue combination in medical termination of pregnancy up to and beyond 7 weeks of amenorrhea: The RYMMa study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Amenorrhea; Female; France; Humans; Longitudinal Studies; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Young Adult | 2020 |
The role of parity in medical abortion up to 49 days of amenorrhoea.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Amenorrhea; Chorionic Gonadotropin; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies; Risk Factors; ROC Curve; Young Adult | 2008 |
Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Buccal; Adult; Ambulatory Care Facilities; Amenorrhea; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Netherlands Antilles; Pregnancy; Prospective Studies; Self Administration; Treatment Outcome; Young Adult | 2011 |
Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor.
Topics: Amenorrhea; Cell Proliferation; Contraceptive Agents; Contraceptives, Oral, Synthetic; Endometrium; Female; Glucocorticoids; Humans; Immunohistochemistry; Microcirculation; Mifepristone; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Glucocorticoid; Vascular Endothelial Growth Factor A | 2006 |
Chronic antiprogestin therapy produces a stable atrophic endometrium with decreased fibroblast growth factor: a 1-year primate study on contraception and amenorrhea.
Topics: Amenorrhea; Animals; Contraception; Endometrium; Female; Fibroblast Growth Factor 2; Hormone Antagonists; Leuprolide; Macaca fascicularis; Mifepristone; Ovulation | 1998 |
Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Amenorrhea; Endocrine Glands; Endometriosis; Female; Hormones; Humans; Hydrocortisone; Laparoscopy; Mifepristone; Palliative Care; Pelvic Neoplasms; Progesterone; Time Factors | 1991 |
[Use of mifepristone in the termination of early pregnancy. The experience in France].
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Legal; Amenorrhea; Estrenes; Female; France; Humans; Mifepristone; Pregnancy; Prostaglandins | 1989 |
Pregnancy interruption with RU 486 in combination with dl-15-methyl-prostaglandin-F2 alpha-methyl ester: the Chinese experience.
Topics: Adult; Amenorrhea; Arbaprostil; China; Drug Evaluation; Drug Synergism; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy, Unwanted; Prostaglandins E, Synthetic | 1988 |
Fertility control in women: results with RU 486 by the end of 1985.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Amenorrhea; Contraceptives, Postcoital; Estrenes; Female; Humans; Mifepristone; Models, Biological; Pregnancy | 1986 |